| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/05/2004 | US20040152172 Generating pool of RNA interfering sequences via transformation, expression and recovery of cloned vector sequences associated with full hairpin random oligonucleotides; gene expression inhibition |
| 08/05/2004 | US20040152171 Propagating escherichia mutant which produces 5'-inosinic acid or 5'-guanylic acid; identifying nucleotidase gene associated with generating nucleoside 5'-phosphate esters |
| 08/05/2004 | US20040152169 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
| 08/05/2004 | US20040152168 Genetically engineered cells comprising expression vectgor coding transcription factor polypeptide for use in transformation of stem cells and generation of pancreatic tissue; insulin delivery tool and diabetes treatment |
| 08/05/2004 | US20040152167 Peptide associated with transcobalamin for use in diagnosis, prevention and treatment of cell prolifefrative disorders |
| 08/05/2004 | US20040152165 Lipopolysaccharide alpha -2,3 sialyltransferase of campylobacter jejuni and its uses |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152158 Cis-prenyltransferases from plants |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152124 Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152122 simple in the design and easy to miniaturize and integrate into complex apparatuses; uses non-thermostable polymerases; temperature distribution that induces circulation so that the denaturation, annealing, and polymerization occur sequentially |
| 08/05/2004 | US20040152120 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 08/05/2004 | US20040152117 involve the use of double stranded RNA expression libraries; selectively regulates expression of genes in vertebrate cells without the associated toxicity of interferon response |
| 08/05/2004 | US20040152116 G-quadruplex binding assays and compounds therefor |
| 08/05/2004 | US20040152114 high washing efficiency where contamination does not occur and liquid does not remain in the nozzle tip; washing solution is fed into said tip unidirectionally from head to end; solid phase synthesis |
| 08/05/2004 | US20040152112 Compositions and methods for cancer diagnosis and therapy |
| 08/05/2004 | US20040152105 Immune modulatory compounds and methods |
| 08/05/2004 | US20040152103 by co-expressing polypeptides using escherichia coli; immunoglobulins; single chain FV fragments; genetic engineering |
| 08/05/2004 | US20040152101 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering |
| 08/05/2004 | US20040152099 for the preparation of a live carrier for the expression of at least one heterologous antigen or of a live vaccine; for in vivo drug screening |
| 08/05/2004 | US20040152098 Cellular signal-responsive gene transcriptional regulation system |
| 08/05/2004 | US20040152094 Method for producing recombined polynucleotides |
| 08/05/2004 | US20040152092 Cancer therapy, cardiovascular disorders, central nervous system disorders, asthma, antidiabetic agents |
| 08/05/2004 | US20040152090 Method for the amplificaton and detection of dna using a transcription based amplification |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152083 Multiple arrays with surface energy transition to maintain separation of samples on the arrays |
| 08/05/2004 | US20040152080 Pretreatment Dna; amplification using polymerase primers; incubation in solution of hydrogen sulfite; polymerase chain reactions; brain disorders; skin disorders; bone disorders; antiinflammatory agents; headaches; sexual disorders |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152077 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 08/05/2004 | US20040152076 Purification; separation of impurities from foods;, drugs chelation |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040152072 Reverse transcription |
| 08/05/2004 | US20040152069 Synthetic gagpol genes and their uses |
| 08/05/2004 | US20040152066 Enhance gene expression; water diffusion or transferring through cell membrane; frozen dough |
| 08/05/2004 | US20040151795 Cast secondary part for electric motors |
| 08/05/2004 | US20040151775 Membrane active polymers |
| 08/05/2004 | US20040151730 Methods of selecting polynucleotides encoding antigens |
| 08/05/2004 | US20040151723 specific to cancerous and precancerous lesions of the uterus |
| 08/05/2004 | US20040151720 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/05/2004 | US20040151713 Cell cycle regulatory factor |
| 08/05/2004 | US20040151707 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
| 08/05/2004 | US20040151696 preferentially kill neoplastic but not normal cells, the preferred vector being an adenovirus that has the endogenous promoters in the E1A and/or E4 regions substituted with a tumor specific promoter which is preferably E2F responsive. |
| 08/05/2004 | US20040151695 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 08/05/2004 | US20040151689 poly(propyleneimine interiors and poly(amidoamine) exteriors for use in transfection and imaging applications; may contain nucleic acid, metal or drug guest molecules; ballistically accelerating dendrimer/nucleic acid complexes at target cells |
| 08/05/2004 | US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens |
| 08/05/2004 | DE10302360A1 Storing information in the genome, useful for genetic labeling, comprises inserting a synthetic nucleic acid, encoding the information, into a non-coding part of the host's genome |
| 08/05/2004 | CA2648056A1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 08/05/2004 | CA2553313A1 Cationic graft-copolymer for non-viral gene delivery vector |
| 08/05/2004 | CA2517469A1 .beta.1,3-n-acetyl-d-galactosaminyltransferase protein and nucleic acid encoding the same, as well as canceration assay using the same |
| 08/05/2004 | CA2514305A1 A hybrid vector system for use as a vaccine |
| 08/05/2004 | CA2514184A1 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| 08/05/2004 | CA2513797A1 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 08/05/2004 | CA2513744A1 Depletion of endogenous primordial germ cells in avian species |
| 08/05/2004 | CA2513730A1 Method for comprehensive identification of cell lineage specific genes |
| 08/05/2004 | CA2513679A1 Small interference rna gene therapy |
| 08/05/2004 | CA2513623A1 Compositions and methods for sirna inhibition of icam-1 |
| 08/05/2004 | CA2513559A1 Herpesvirus amplicon particles |
| 08/05/2004 | CA2513470A1 Modulation of deubiquitinase family members |
| 08/05/2004 | CA2513354A1 Modulation of thyroid hormone receptor interactor 3 expression |
| 08/05/2004 | CA2513289A1 Expression cassette with promotors of starch synthesis 3 for the expression of nucleic acids in plant tissue containing starch |
| 08/05/2004 | CA2513182A1 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders |
| 08/05/2004 | CA2513004A1 Aptamer therapeutics useful in ocular pharmacotherapy |
| 08/05/2004 | CA2512917A1 Methods for increasing neisseria protein expression |
| 08/05/2004 | CA2510003A1 Synthetic antibody phage libraries |
| 08/04/2004 | EP1443449A2 Apparatus, method and computer readable medium for encoding a DNA sequence |
| 08/04/2004 | EP1443438A1 Dna providing system |
| 08/04/2004 | EP1443118A1 Primers for detecting Fusobacterium nucleatum by PCR methods and methods for detection |
| 08/04/2004 | EP1443113A1 Method of obtaining indolocarbazoles using biosynthetic rebeccamycin genes |
| 08/04/2004 | EP1443112A2 Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/04/2004 | EP1443111A1 Desmin gene having novel point mutation causative of dilated cardiomyopathy |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1443107A1 Preparing somatic embryo by utilizing rabbit oocyte |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443055A2 Interleukins-21 and 22 |
| 08/04/2004 | EP1443054A1 Anitmicrobial proteins, genes encoding the proteins and mehtod of using the same |
| 08/04/2004 | EP1443053A1 Analgesic antitumor peptide from scorpion and method of producing it |
| 08/04/2004 | EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression |
| 08/04/2004 | EP1442794A2 System and method for carrying out and monitoring biological processes |
| 08/04/2004 | EP1442789A1 Multiple arrays |
| 08/04/2004 | EP1442751A1 Method of imaging |
| 08/04/2004 | EP1442747A1 Superoxide dismutase and mimetics thereof |
| 08/04/2004 | EP1442295A2 Periostin-based diagnostic assays |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442140A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 08/04/2004 | EP1442137A2 Universal nucleotides for nucleic acid analysis |
| 08/04/2004 | EP1442136A1 Apparatus for circulating carrier fluid |
| 08/04/2004 | EP1442135A2 Devices and methods for detecting genetic sequences |
| 08/04/2004 | EP1442134A2 Method for producing and identifying soluble protein domains |
| 08/04/2004 | EP1442132A2 Methods for the treatment of osteoarthritis and compositions thereof |
| 08/04/2004 | EP1442129A1 Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes |
| 08/04/2004 | EP1442128A2 Production, detection and use of transformant cells |